ARTICLE | Politics, Policy & Law
Facing likely loss in courts, FTC blinks in Amgen case
FTC settles, allowing Amgen to acquire Horizon, but reiterates suspicion of biopharma M&A, intention to apply new theories to regulate the industry
September 1, 2023 5:38 PM UTC
Dodging the risk of a loss in the courts that could have set back its attempts to restrict biopharma M&A, the FTC has reached an agreement with Amgen that will allow the company’s $27.8 billion acquisition of Horizon to proceed.
Amgen Inc. (NASDAQ:AMGN) said it expects to complete the acquisition early next quarter...